The clinical impact of frailty in transplant ineligible patients with multiple myeloma treated with bortezomib-based chemotherapy as front line therapy

被引:0
作者
Lee, Ho Sup [1 ]
Kim, Da Jung [1 ]
Lee, Ji Hyun [2 ]
Lee, Je-Jung [3 ]
Jung, Sung-Hoon [3 ]
Jo, Jae-Cheol [4 ]
Lee, Yoo Jin [4 ]
Shin, Ho-Jin [5 ]
Lee, Won [6 ]
机构
[1] Kosin Univ, Coll Med, Busan, South Korea
[2] Dong A Univ, Coll Med, Busan, South Korea
[3] Chonnam Natl Univ, Hwasun Hosp, Hwasun Gun, Jeollanam Do, South Korea
[4] Ulsan Univ Hosp, Ulsan, South Korea
[5] Pusan Natl Univ Hosp, Busan, South Korea
[6] Busan Paik Hosp, Busan, South Korea
关键词
bortezomib; frailty; Multiple myeloma;
D O I
10.1016/j.clml.2019.09.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OAB-015
引用
收藏
页码:E11 / E12
页数:2
相关论文
共 50 条
[31]   Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study [J].
Pula, Anna ;
Robak, Tadeusz ;
Drozdz, Izabela ;
Stawiski, Konrad ;
Rycerz, Aleksander ;
Misiewicz, Malgorzata ;
Robak, Pawel .
LEUKEMIA & LYMPHOMA, 2024, 65 (02) :257-264
[32]   The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens [J].
Pula, Anna ;
Robak, Pawel ;
Jarych, Dariusz ;
Mikulski, Damian ;
Misiewicz, Malgorzata ;
Drozdz, Izabela ;
Fendler, Wojciech ;
Szemraj, Janusz ;
Robak, Tadeusz .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
[33]   Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma [J].
Manochakian, Rami ;
Miller, Kena C. ;
Chanan-Khan, Asher A. .
ONCOLOGIST, 2007, 12 (08) :978-990
[34]   The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen [J].
Zhang, Quane ;
Wang, Yifan ;
Shi, Wenting ;
Chen, Yue ;
He, Zhengmei ;
Yu, Liang ;
Wang, Chunling .
SCIENTIFIC REPORTS, 2025, 15 (01)
[35]   Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice [J].
Terpos, Evangelos ;
Katodritou, Eirini ;
de la Rubia, Javier ;
Hungria, Vania ;
Hulin, Cyrille ;
Roussou, Maria ;
Delforge, Michel ;
Bries, Greet ;
Stoppa, Anne-Marie ;
Aagesen, Jesper ;
Sargin, Deniz ;
Belch, Andrew ;
Ahlberg, Lucia ;
Diels, Joris ;
Olie, Robert A. ;
Robinson, Don, Jr. ;
Spencer, Mike ;
Potamianou, Anna ;
van de Velde, Helgi ;
Dimopoulos, Meletios A. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (04) :556-565
[36]   Bortezomib-based Chemotherapy and Bone-marrow Followed by Renal Transplantation in Multiple Myeloma: A Literature Review [J].
Sethi, Jasmine ;
Sulaiman, Shabna ;
Ramachandran, Raja ;
Prakash, Gaurav ;
Kanwar, Deepesh ;
Nada, Ritambhra ;
Rathi, Manish ;
Kohli, Harbir Singh .
INDIAN JOURNAL OF TRANSPLANTATION, 2025, 19 (02) :150-156
[37]   Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib [J].
Iriyama, Noriyoshi ;
Miura, Katsuhiro ;
Hatta, Yoshihiro ;
Kobayashi, Sumiko ;
Uchino, Yoshihito ;
Kurita, Daisuke ;
Sakagami, Hitomi ;
Takahashi, Hiromichi ;
Sakagami, Masashi ;
Kobayashi, Yujin ;
Nakagawa, Masaru ;
Ohtake, Shimon ;
Iizuka, Yoshikazu ;
Takei, Masami .
ONCOLOGY LETTERS, 2017, 13 (05) :3803-3808
[38]   The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma [J].
Cherniawsky, Hannah M. ;
Kukreti, Vishal ;
Reece, Donna ;
Masih-Khan, Esther ;
McCurdy, Arleigh ;
Jimenez-Zepeda, Victor H. ;
Sebag, Michael ;
Song, Kevin ;
White, Darrell ;
Stakiw, Julie ;
LeBlanc, Richard ;
Reiman, Anthony ;
Louzada, Martha ;
Aslam, Muhammad ;
Kotb, Rami ;
Gul, Engin ;
Atenafu, Eshetu ;
Venner, Christopher P. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (05) :673-681
[39]   Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens [J].
Roussou, Maria ;
Kastritis, Efstathios ;
Migkou, Magdalini ;
Psimenou, Erasmia ;
Grapsa, Irini ;
Matsouka, Charis ;
Barmparousi, Despina ;
Terpos, Evangelos ;
Dimopoulos, Meletios Athanasios .
LEUKEMIA & LYMPHOMA, 2008, 49 (05) :890-895
[40]   Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients [J].
Liu, Zhaoyun ;
Shen, Hongli ;
Han, Mei ;
Zhao, Xianghong ;
Liu, Hui ;
Ding, Kai ;
Song, Jia ;
Fu, Rong .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130